Patents Assigned to OPAL THERAPEUTICS PTY LTD
  • IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR
    Publication number: 20110008417
    Abstract: This invention discloses compositions that consist essentially of a Gag polypeptide or at least one portion thereof, and optionally antigen-presenting cells or their precursors, for treating or preventing lentiviral infections including the treatment or prevention of related acquired immunodeficiency diseases. In certain embodiments, the compositions consist essentially of a plurality of overlapping and/or non-overlapping peptides derived from a single Gag polypeptide or from different Gag polypeptides.
    Type: Application
    Filed: January 16, 2008
    Publication date: January 13, 2011
    Applicant: OPAL THERAPEUTICS PTY LTD
    Inventors: Vivienne Peut, Robert De Rose, Stephen Kent